oxybutynin has been researched along with capsaicin in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (6.58) | 29.6817 |
| 2010's | 59 (77.63) | 24.3611 |
| 2020's | 12 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, CJ | 1 |
| Doi, T; Ikeura, Y; Imai, S; Kamo, I; Natsugari, H; Okanishi, S | 1 |
| Cannon, TW; Chancellor, MB | 1 |
| Goepel, M; Grigoleit, U; Pannek, J; Wormland, R | 1 |
| Bhattacharji, S; George, J; Macaden, AS; Richar, J; Tharion, G; Thomas, R | 1 |
| Chen, B; Pan, X; Peng, X; Wang, R; Wen, X; Wu, C | 1 |
| Lam, VY; Schulteis, G; Wallace, M | 1 |
| Rauck, R; Tark, M; Tobias, JK; Vanhove, GF; Webster, LR | 1 |
| Backonja, MM; Blonsky, ER; Dunteman, E; Irving, GA; Lu, SP; Tobias, J; Vanhove, GF | 1 |
| Andresen, T; Arendt-Nielsen, L; Christrup, LL; Drewes, AM; Foster, DJ; Upton, RN | 1 |
| Pappagallo, M; Wallace, M | 1 |
| Armstrong, EP; Malone, DC; McCarberg, B; Panarites, CJ; Pham, SV | 1 |
| Jones, VM; Moore, KA; Peterson, DM | 1 |
| Lu, B; Murphy, FT; Peppin, JF; Tobias, JK; Vanhove, GF; Webster, LR | 1 |
| Krause, K; Magerl, M; Maurer, M; Metz, M | 1 |
| Argoff, CE | 1 |
| Han, W; Tang, X; Wang, C; Zhang, H | 1 |
| Brodsky, M; Cho, JH; Cho, YJ; Fang, JY; Kim, EJ; Kim, KW; Song, MY | 1 |
| Kiss, G | 1 |
| Arendt, G; Baron, R; Birklein, F; Cegla, T; Freynhagen, R; Gockel, HH; Heskamp, ML; Husstedt, IW; Jager, H; Joppich, R; Kern, KU; Leffler, A; Maier, C; Nagelein, HH; Rolke, R; Seddigh, S; Sommer, C; Stander, S; Treede, RD; Wagner, T; Wasner, G | 1 |
| Brown, S; Simpson, DM; Tobias, JK; Vanhove, GF | 1 |
| Heskamp, ML; Maihofner, C | 1 |
| Dahan, A; Krebs-Brown, A; Martini, CH; Olofsen, E; Passier, P; Stoker, M; Yassen, A | 1 |
| Katz, NP; Mou, J; Paillard, F; Stoker, M; Trudeau, J; Turnbull, B | 2 |
| Poole, C; Roth-Daniek, A; Wagner, T | 1 |
| Bleuel, I; Tappeiner, C; Tschopp, M; Zinkernagel, M | 1 |
| Agis, ER; Demirel-Yilmaz, E; Ercan, N; Uludag, MO | 1 |
| Knolle, E; Kovacs, GG; Medwed, S; Scharbert, G; Schemper, M; Zadrazil, M | 1 |
| Keavney, J; Murphy, K; O'Brien, J; Pollard, V; Weekes, G | 1 |
| Anand, P; Gibbs, JS; Gin-Sing, W; Huson, L; Iddamalgoda, T; Khengar, RH; Libri, V; Pinato, DJ | 1 |
| Kern, KU; Nowack, W; Poole, C | 1 |
| Ernault, E; Fricová, J; Høye, K; Jensen, TS; Marques, S; Siciliano, T; Vanelderen, P | 1 |
| Gaul, C; Resch, S | 1 |
| Heskamp, ML; Michael, J; Neubert, RH; Wohlrab, J | 1 |
| Bischoff, JM; Petersen, M; Ringsted, TK; Sommer, C; Uçeyler, N; Werner, MU | 1 |
| Augustin, M; Dieckhöfer, A; Lüling, H; Osada, N; Schedel, F; Ständer, S; Steinke, S; Zeidler, C | 1 |
| An, YJ; Jin, TE; Kim, DH; Park, S; Schepis, EA; Yoon, DM; Yoon, KB | 1 |
| Grüneberg-Oelker, U; Husstedt, IW; Philipp, K; Raber, JM; Reichelt, D; Stubbe-Dräger, B | 1 |
| Katz, NP; Mou, J; Paillard, FC; Stoker, M; Trudeau, J; Turnbull, B | 1 |
| Bogdanovich, A; Busquets, C; Faulí, A; Giménez-Milà, M; Hernández-Cera, C; Moreno, LA; Navarro, MA; Ojeda, A; Videla, S | 1 |
| Brenaut, E; Castela, E; Erfan, N; Lacour, JP; Lantéri-Minet, M; Misery, L; Passeron, T | 1 |
| Trbovich, M; Yang, H | 1 |
| Abdulahad, AK; Bosilkov, A; Chambers, C; Cruccu, G; Docu Axelarad, A; Ernault, E; Haanpää, M; McBride, WT; Nurmikko, TJ | 1 |
| Burness, CB; McCormack, PL | 1 |
| Andersen, HH; Elberling, J; Sand, C | 1 |
| Augustin, M; Dieckhöfer, AM; Gutknecht, M; Herrlein, O; Lüling, H; Ständer, S; Steinke, S; Zeidler, C | 1 |
| Jacobs, H; Katz, N; Lambourg, B; Long, SK; Robinson-Papp, J; Schregardus, DS; Simpson, DM; Snijder, RJ; Stoker, M; Van, J | 1 |
| Andersen, HH; Arendt-Nielsen, L; Elberling, J; Hoeck, EA; Marker, JB | 1 |
| Choi, E; Kim, YC; Lee, PB; Lee, SC; Moon, JY; Nahm, FS | 1 |
| Aitken, E; Kingsmore, D; McColl, G | 1 |
| Charokopou, M; Pantiri, K; Stoker, M; Treur, M; van Nooten, F | 1 |
| Berni, E; Calvo, JI; Currie, CJ; Ernault, E; Mankowski, C; Odeyemi, I; Plastira, C; Poole, CD; Thomas, R; Treadwell, C; Zafeiropoulou, E | 1 |
| Frutiger, K; Heininger, A; Light, A; Wessman, K; White, RJ | 1 |
| Filipczak-Bryniarska, I; Grodzicki, T; Kazior, L; Kleja, J; Krzemieniecki, K; Krzyzewski, RM; Kucharz, J; Michalowska-Kaczmarczyk, A; Strzepek, K; Wordliczek, J; Woron, J | 1 |
| Attal, N; Ernault, E; Gálvez, R; Maihöfner, C; Moyle, G; Navez, ML; Nurmikko, TJ; Stoker, M | 1 |
| Dieckhöfer, A; Lüling, H; Pereira, MP; Ständer, S; Steinke, S; Zeidler, C | 1 |
| Hansson, P; Jensen, TS; Kvarstein, G; Strömberg, M | 1 |
| Agelopoulos, K; Dieckhöfer, A; Lüling, H; Pereira, MP; Ständer, S; Steinke, S; Zeidler, C | 1 |
| Fernandes, HL; Gama, R; Loureiro, MC; Pereira, FC; Tenreiro Pinto, J | 1 |
| Blair, HA | 1 |
| Azad, SC; Luchting, B | 1 |
| Lantéri-Minet, M; Perrot, S | 1 |
| Cohrs, J; Kerns, R | 1 |
| Gestosa, SVS; Lares, AMG; Mulenas, NME; Ruivo, EFM | 1 |
| Akyuz, L; Aylanc, V; Bilican, I; Cakmak, YS; Ertosun, S; Gokdag, S; Kaya, M; Koc Bilican, B; Yilmaz, BA | 1 |
| Bonezzi, C; Costantini, A; Cruccu, G; Dickenson, AH; Fornasari, DMM; Guardamagna, V; Palmieri, V; Polati, E; Zini, P | 1 |
| Cabezón-Gutiérrez, L; Custodio-Cabello, S; Khosravi-Shahi, P; Palka-Kotlowska, M | 1 |
| Barbosa, P; Gomes, A; Goncalves, D; Rebelo, V | 1 |
| Hascalovici, JR; Nair, S; Shaparin, N; Vydyanathan, A | 1 |
| Economou, S; Samara, E; Stamatiou, K; Tzimas, P | 1 |
| Argoff, C; Eerdekens, M; Engelen, S; Freynhagen, R; Perrot, S | 1 |
| Casale, R | 1 |
| Ausín-Crespo, MD; de la Beldad-Diez, ML; Martín-de Castro, E; Roldán-Cuartero, J; Salcedo-Gámez, MÁ; Tong, H | 1 |
| Assuncao, JP; Cardoso, C; de Castro, AM; Loureiro, MDC; Pinto, J; Vieira, IF | 1 |
15 review(s) available for oxybutynin and capsaicin
| Article | Year |
|---|---|
Intravesical treatment of overactive bladder.
Topics: Administration, Intravesical; Anesthetics, Local; Atropine; Capsaicin; Cholinergic Antagonists; Diterpenes; Humans; Mandelic Acids; Neurons, Afferent; Neurotoxins; Urinary Bladder Diseases; Urinary Incontinence | 2000 |
Pharmacotherapy of the overactive bladder and advances in drug delivery.
Topics: Administration, Intravesical; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxins; Capsaicin; Cholinergic Antagonists; Cresols; Cystitis, Interstitial; Diterpenes; Humans; Mandelic Acids; Neurotoxins; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases; Urination Disorders | 2002 |
Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
Topics: Administration, Cutaneous; Capsaicin; Clinical Trials as Topic; Europe; Humans; Neuralgia, Postherpetic; Sensory System Agents; Transdermal Patch; TRPV Cation Channels; United States | 2011 |
Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Topics: Administration, Topical; Amines; Anesthetics, Local; Antidepressive Agents, Tricyclic; Capsaicin; Clinical Trials as Topic; Costs and Cost Analysis; Cyclohexanecarboxylic Acids; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Male; Markov Chains; Neuralgia, Postherpetic; Pregabalin; Quality of Life; Sensory System Agents; Thiophenes; Transdermal Patch | 2011 |
Review of current guidelines on the care of postherpetic neuralgia.
Topics: Amines; Analgesics; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Neuralgia, Postherpetic; Practice Guidelines as Topic; Pregabalin; Primary Health Care; Tramadol; Transdermal Patch | 2011 |
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
Topics: Adolescent; Adult; Capsaicin; Child; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Neuralgia; Pain Management; Practice Guidelines as Topic; Sensory System Agents; Time Factors; Transdermal Patch | 2013 |
Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.
Topics: Aged; Aged, 80 and over; Capsaicin; Clinical Trials as Topic; Databases, Factual; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Neuralgia; Sensory System Agents; Transdermal Patch | 2013 |
Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
Topics: Adult; Aged; Aged, 80 and over; Capsaicin; Databases, Factual; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Sensory System Agents; Time Factors; Transdermal Patch; Young Adult | 2014 |
Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Topics: Capsaicin; Diabetic Neuropathies; Humans; Neuralgia, Postherpetic; Pain Management; Peripheral Nervous System Diseases; Pregabalin; Sensory System Agents; Transdermal Patch | 2016 |
Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
Topics: Administration, Oral; Analgesics; Capsaicin; Diabetic Neuropathies; Humans; Neuralgia; Transdermal Patch | 2017 |
Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Pain Management; Pregabalin; Transdermal Patch; TRPV Cation Channels | 2018 |
Pain therapy for the elderly patient: is opioid-free an option?
Topics: Administration, Topical; Age Factors; Aged; Aging; Analgesics, Non-Narcotic; Analgesics, Opioid; Capsaicin; Chronic Pain; Humans; Pain Management; Pain Measurement; Transdermal Patch; Treatment Outcome | 2019 |
Capsaicin 8% dermal patch in clinical practice: an expert opinion.
Topics: Administration, Topical; Analgesics; Capsaicin; Cost-Benefit Analysis; Expert Testimony; Humans; Neuralgia; Pregabalin; Quality of Life; Transdermal Patch; TRPV Cation Channels | 2020 |
High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review.
Topics: Antineoplastic Agents; Capsaicin; Humans; Peripheral Nervous System Diseases; Prospective Studies; Retrospective Studies; Transdermal Patch | 2020 |
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy.
Topics: Adult; Capsaicin; Diabetic Neuropathies; Humans; Neuralgia; Neuralgia, Postherpetic; Pain, Postoperative; Transdermal Patch | 2021 |
25 trial(s) available for oxybutynin and capsaicin
| Article | Year |
|---|---|
[Intravesical therapy for overactive bladder].
Topics: Administration, Intravesical; Adolescent; Adult; Capsaicin; Child; Child, Preschool; Drug Delivery Systems; Female; Humans; Iontophoresis; Male; Mandelic Acids; Middle Aged; Treatment Outcome; Urinary Incontinence | 2006 |
The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
Topics: Administration, Intravesical; Adolescent; Adult; Capsaicin; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Middle Aged; Propantheline; Spinal Cord Injuries; Time Factors; Urinary Bladder, Neurogenic | 2007 |
Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial.
Topics: Anesthetics, Local; Capsaicin; Double-Blind Method; Humans; Hyperalgesia; Injections, Intradermal; Lidocaine; Pain; Pain Measurement; Pain Threshold; Time Factors; Transdermal Patch | 2011 |
Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
Topics: Aged; Capsaicin; Double-Blind Method; Female; Humans; Male; Neuralgia, Postherpetic; Pain Measurement; Sensory System Agents; Time; Transdermal Patch | 2010 |
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
Topics: Administration, Topical; Aged; Analgesics; Capsaicin; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Neuralgia, Postherpetic; Pain Measurement; Socioeconomic Factors; Transdermal Patch; Treatment Outcome | 2011 |
Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Capsaicin; Cold Temperature; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Fentanyl; Hot Temperature; Humans; Hyperalgesia; Male; Models, Biological; Pain; Pain Measurement; Time Factors; Transdermal Patch; Young Adult | 2011 |
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
Topics: Aged; Anesthetics, Local; Capsaicin; Diabetic Neuropathies; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Peripheral Nervous System Diseases; Polyneuropathies; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2011 |
Efficacy of a 0.1% capsaicin hydrogel patch for myofascial neck pain: a double-blinded randomized trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Bandages, Hydrocolloid; Capsaicin; Double-Blind Method; Facial Pain; Female; Humans; Male; Middle Aged; Neck Pain; Pain Measurement; Sensory System Agents; Transdermal Patch; Treatment Outcome; Young Adult | 2012 |
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Topics: Adult; Capsaicin; Double-Blind Method; Endpoint Determination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neuralgia; Neurologic Examination; Pain Management; Pain Measurement; Patient Satisfaction; Peripheral Nervous System Diseases; Sensory Receptor Cells; Skin; Transdermal Patch; Treatment Outcome | 2014 |
Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Transdermal Patch; Treatment Outcome | 2013 |
A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
Topics: Aged; Aged, 80 and over; Capsaicin; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Transdermal Patch; Treatment Outcome | 2013 |
Comparison of cooling and EMLA to reduce the burning pain during capsaicin 8% patch application: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Capsaicin; Cryotherapy; Double-Blind Method; Female; Follow-Up Studies; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Ointments; Pain; Pain Management; Pain Measurement; Prilocaine; Transdermal Patch; Young Adult | 2013 |
Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients.
Topics: Adult; Aged; Antihypertensive Agents; Capsaicin; Double-Blind Method; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Infusions, Subcutaneous; London; Male; Middle Aged; Pain; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2014 |
Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Capsaicin; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Pain Measurement; Premedication; Sensory System Agents; Single-Blind Method; Tramadol; Transdermal Patch; Treatment Outcome | 2014 |
A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Capsaicin; Female; Hernia, Inguinal; Humans; Male; Middle Aged; Pain; Pain Management; Pain Measurement; Risk Factors; Skin; Surveys and Questionnaires; Transdermal Patch | 2014 |
Comparison of NSAID patch given as monotherapy and NSAID patch in combination with transcutaneous electric nerve stimulation, a heating pad, or topical capsaicin in the treatment of patients with myofascial pain syndrome of the upper trapezius: a pilot st
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Female; Hot Temperature; Humans; Male; Middle Aged; Myofascial Pain Syndromes; Pilot Projects; Sensory System Agents; Single-Blind Method; Superficial Back Muscles; Transcutaneous Electric Nerve Stimulation; Transdermal Patch; Young Adult | 2014 |
Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain.
Topics: Adult; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2015 |
Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
Topics: Adult; Aged; Aged, 80 and over; AIDS-Associated Nephropathy; Analysis of Variance; Capsaicin; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Male; Middle Aged; Neuralgia, Postherpetic; Pain Measurement; Predictive Value of Tests; Sensory System Agents; Time Factors; Transdermal Patch; Treatment Outcome; Young Adult | 2015 |
Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Pain Measurement; Pregabalin; Transdermal Patch; Treatment Outcome; Young Adult | 2016 |
Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Blood Glucose; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Pain Measurement; Sensory System Agents; Sleep Wake Disorders; Statistics, Nonparametric; Time Factors; Transdermal Patch | 2017 |
Antipruritic effect of pretreatment with topical capsaicin 8% on histamine- and cowhage-evoked itch in healthy volunteers: a randomized, vehicle-controlled, proof-of-concept trial.
Topics: Administration, Cutaneous; Antipruritics; Capsaicin; Cross-Over Studies; Double-Blind Method; Female; Forearm; Healthy Volunteers; Histamine; Humans; Male; Mucuna; Pruritus; Transdermal Patch; Young Adult | 2017 |
Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
Topics: Capsaicin; Double-Blind Method; Humans; Neuralgia; Pain Management; Pain Measurement; Transdermal Patch; Treatment Outcome | 2017 |
Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Topics: Adult; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Pain Measurement; Quality of Life; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2017 |
High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.
Topics: Aged; Analgesics, Non-Narcotic; Antineoplastic Agents; Capsaicin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Transdermal Patch; Treatment Outcome | 2017 |
Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
Topics: Aged; Analgesics, Non-Narcotic; Capsaicin; Female; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Prospective Studies; Reflex; Sensation; Transdermal Patch; Treatment Outcome | 2017 |
36 other study(ies) available for oxybutynin and capsaicin
| Article | Year |
|---|---|
Effects of TAK-637, a tachykinin receptor antagonist, on the micturition reflex in guinea pigs.
Topics: Animals; Benzhydryl Compounds; Benzilates; Capsaicin; Cholinergic Antagonists; Cresols; Dilatation; Dose-Response Relationship, Drug; Guinea Pigs; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle Relaxants, Central; Naphthyridines; Parasympatholytics; Phenylpropanolamine; Piperidines; Propiophenones; Receptors, Tachykinin; Reflex; Tolterodine Tartrate; Urinary Bladder; Urination | 2000 |
Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels.
Topics: Administration, Cutaneous; Capsaicin; Delayed-Action Preparations; Diffusion; Drug Design; Drug Evaluation, Preclinical; Gels; Phase Transition; Transdermal Patch | 2010 |
Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
Topics: Administration, Cutaneous; Capsaicin; Clinical Trials as Topic; Humans; Neuralgia, Postherpetic; Pain Measurement; Sensory System Agents; Transdermal Patch; TRPV Cation Channels | 2011 |
Treatment of notalgia paraesthetica with an 8% capsaicin patch.
Topics: Aged; Antipruritics; Capsaicin; Female; Humans; Middle Aged; Paresthesia; Prurigo; Transdermal Patch | 2011 |
Evaluation of drug release profile from patches based on styrene-isoprene-styrene block copolymer: the effect of block structure and plasticizer.
Topics: Administration, Cutaneous; Calorimetry, Differential Scanning; Capsaicin; Chemistry, Pharmaceutical; Chromatography, Gel; Crystallography, X-Ray; Diffusion; Diphenhydramine; Drug Carriers; Elastomers; Kinetics; Microscopy, Atomic Force; Models, Chemical; Molecular Structure; Plasticizers; Polystyrenes; Rheology; Salicylates; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Terpenes; Transdermal Patch; Water | 2012 |
[Practical information about Qutenza patch: capsaicin "reloaded"].
Topics: Analgesics, Non-Narcotic; Capsaicin; Humans; Neuralgia; Transdermal Patch | 2012 |
The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
Topics: Capsaicin; Failed Back Surgery Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Pain Management; Pain Measurement; Radiculopathy; Retrospective Studies; Sensory System Agents; Transdermal Patch; Treatment Outcome; Trigeminal Neuralgia | 2013 |
Association of bilateral acute anterior uveitis with a capsaicin patch.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Capsaicin; Female; Humans; Neck Pain; Ophthalmic Solutions; Prednisolone; Prodrugs; Sensory System Agents; Transdermal Patch; Uveitis, Anterior | 2013 |
The anti-inflammatory effect of diclofenac is considerably augmented by topical capsaicinoids-containing patch in carrageenan-induced paw oedema of rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Capsicum; Carrageenan; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Female; Fruit; Herb-Drug Interactions; Injections, Intramuscular; Injections, Subcutaneous; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Sensory System Agents; Transdermal Patch | 2013 |
Qutenza patch--our early experience.
Topics: Activities of Daily Living; Analgesics; Capsaicin; Chronic Pain; Humans; Neuralgia; Pain Measurement; Sleep; Surveys and Questionnaires; Transdermal Patch; Treatment Outcome | 2013 |
Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
Topics: Analgesics; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Dipyrone; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Pain Measurement; Pirinitramide; Time Factors; Transdermal Patch; Treatment Outcome | 2014 |
Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.
Topics: Aged; Capsaicin; Face; Female; Head; Humans; Male; Middle Aged; Neuralgia; Sensory System Agents; Transdermal Patch; Young Adult | 2015 |
Cutaneous drug delivery of capsaicin after in vitro administration of the 8% capsaicin dermal patch system.
Topics: Administration, Cutaneous; Analgesics; Biological Availability; Capsaicin; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Kinetics; Mass Spectrometry; Skin; Skin Absorption; Temperature; Transdermal Patch | 2015 |
Capsaicin 8% cutaneous patch: a promising treatment for brachioradial pruritus?
Topics: Administration, Cutaneous; Aged; Antipruritics; Capsaicin; Female; Forearm; Humans; Middle Aged; Pruritus; Quality of Life; Transdermal Patch; Treatment Outcome | 2015 |
Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics; Capsaicin; Feasibility Studies; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Prospective Studies; Tertiary Care Centers; Time Factors; Transdermal Patch; Treatment Outcome | 2014 |
Successful treatment of refractory neuropathic pruritus with capsaicin 8% patch: a bicentric retrospective study with long-term follow-up.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antipruritics; Capsaicin; Female; France; Humans; Middle Aged; Peripheral Nervous System Diseases; Pruritus; Remission Induction; Retrospective Studies; Time Factors; Transdermal Patch; Treatment Outcome | 2015 |
Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports.
Topics: Adult; Aged; Capsaicin; Humans; Hyperalgesia; Male; Neuralgia; Pain Measurement; Sensory System Agents; Spinal Cord Injuries; Transdermal Patch | 2015 |
[Effective pain relief of post-herpetic neuralgia with capsaicin patch].
Topics: Capsaicin; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain Measurement; Sensory System Agents; Transdermal Patch | 2016 |
Cost-effectiveness of an 8% Capsaicin Patch in the Treatment of Brachioradial Pruritus and Notalgia Paraesthetica, Two Forms of Neuropathic Pruritus.
Topics: Antipruritics; Capsaicin; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Pain Measurement; Paresthesia; Prospective Studies; Pruritus; Quality of Life; Retrospective Studies; Transdermal Patch; Treatment Outcome; Visual Analog Scale | 2017 |
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Topics: Administration, Topical; Adult; Aged; Capsaicin; Cohort Studies; Female; Humans; Ischemia; Kidney Failure, Chronic; Male; Middle Aged; Neuralgia; Peripheral Vascular Diseases; Sensory System Agents; Transdermal Patch | 2017 |
8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain.
Topics: Aged; Antihypertensive Agents; Capsaicin; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Infusions, Subcutaneous; Male; Middle Aged; Pain; Pain Management; Sensory System Agents; Severity of Illness Index; Transdermal Patch | 2017 |
Brachioradial Pruritus and Notalgia Paraesthetica: A Comparative Observational Study of Clinical Presentation and Morphological Pathologies.
Topics: Aged; Antipruritics; Back; Capsaicin; Cervical Vertebrae; Female; Forearm; Ganglia, Spinal; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Compression Syndromes; Paresthesia; Pruritus; Quality of Life; Retrospective Studies; Skin; Spinal Cord Compression; Spinal Nerves; Thoracic Vertebrae; Transdermal Patch | 2018 |
Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Capsaicin; Denmark; Female; Health Status; Humans; Male; Middle Aged; Neuralgia; Norway; Pain Management; Prospective Studies; Quality of Life; Sweden; Transdermal Patch; Treatment Outcome; Young Adult | 2018 |
Application of an 8% capsaicin patch normalizes epidermal TRPV1 expression but not the decreased intraepidermal nerve fibre density in patients with brachioradial pruritus.
Topics: Administration, Cutaneous; Aged; Antipruritics; Capsaicin; Cervical Vertebrae; Epidermis; Female; Forearm; Humans; Keratinocytes; Male; Middle Aged; Nerve Fibers; Peripheral Nerves; Protein Biosynthesis; Pruritus; Spinal Diseases; Transdermal Patch; TRPV Cation Channels | 2018 |
Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
Topics: Administration, Cutaneous; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Pain Measurement; Retrospective Studies; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2018 |
Capsaicin (QUTENZA*) and diabetic neuropathic pain Harmful, and no tangible efficacy.
Topics: Capsaicin; Diabetic Neuropathies; Humans; Sensory System Agents; Transdermal Patch | 2017 |
Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
Topics: Activities of Daily Living; Adult; Aged; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Clinics; Pain Management; Pain Measurement; Prospective Studies; Quality of Life; Transdermal Patch; Treatment Outcome | 2019 |
Using transdermal patches to treat neuropathic pain.
Topics: Anesthetics, Local; Capsaicin; Humans; Lidocaine; Neuralgia; Patient Education as Topic; Transdermal Patch | 2020 |
Peripheral Neuropathy Associated with Hypereosinophilic Syndrome: A Clinical Therapeutic Success with Capsaicin 8% Patch.
Topics: Capsaicin; Humans; Hypereosinophilic Syndrome; Male; Middle Aged; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Quality of Life; Transdermal Patch | 2020 |
Natural β-chitin-protein complex film obtained from waste razor shells for transdermal capsaicin carrier.
Topics: Animal Shells; Animals; Bivalvia; Capsaicin; Chitin; Polymers; Skin; Transdermal Patch | 2020 |
8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Child; Chronic Pain; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Quality of Life; Retrospective Studies; Transdermal Patch; Treatment Outcome; Young Adult | 2020 |
Expanding frontiers in telehealth: Video assisted at-home application of capsaicin 8% patch.
Topics: Capsaicin; Female; Humans; Neuralgia, Postherpetic; Pain Measurement; Sensory System Agents; Telemedicine; Transdermal Patch | 2021 |
Post Laparoscopy Neuropathic Pain Treated by Capsaicin 8% Dermal Patch.
Topics: Capsaicin; Female; Humans; Laparoscopy; Middle Aged; Neuralgia; Transdermal Patch | 2021 |
Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications.
Topics: Capsaicin; Humans; Neuralgia; Prospective Studies; Quality of Life; Transdermal Patch; Treatment Outcome | 2021 |
Capsaicin 8% Dermal Patch for Neuropathic Pain in a Pain Unit.
Topics: Capsaicin; Humans; Neuralgia; Quality of Life; Retrospective Studies; Transdermal Patch | 2022 |
Capsaicin 8% for Peripheral Neuropathic Pain Treatment: A Retrospective Cohort Study.
Topics: Capsaicin; Humans; Neuralgia; Quality of Life; Retrospective Studies; Transdermal Patch | 2022 |